What is the medical term for reduced hand grip strength with sensory loss (inability to feel objects such as a cup or pen)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medical Terminology for Decreased Grip Strength with Sensory Loss

The medical term for decreased grip strength secondary to inability to feel objects is "sensorimotor deficit" or "sensorimotor impairment," which encompasses both the motor weakness (reduced grip strength) and sensory loss (inability to perceive tactile information from objects like cups or pens). 1

Specific Clinical Terms

The combination of motor and sensory deficits affecting hand function can be described using several precise medical terms:

  • Sensorimotor impairment: This is the most comprehensive term that captures both the motor weakness and sensory loss affecting grip strength and object manipulation 1

  • Astereognosia: When the sensory loss specifically impairs the ability to recognize objects by touch (such as identifying a cup or pen without visual input), this term applies 2

  • Tactile apraxia: In cases where parietal lobe lesions cause isolated disturbance of hand movements for object interaction despite preserved sensation, though this typically involves more complex deficits than simple grip weakness 2

Clinical Context and Assessment

The sensory component affecting grip can be quantified through:

  • Sensory testing on the NIHSS (National Institutes of Health Stroke Scale): Scored 0-2, where 1 indicates mild to moderate unilateral sensory loss with patient awareness of touch, and 2 indicates total sensory loss 1

  • Grip and pinch dynamometry: Objective measurement tools available in most rehabilitation settings with normative data for comparison, taking less than 5 minutes to administer 1

Pathophysiological Mechanisms

The inability to feel objects directly impairs grip force control through loss of predictive motor control. 3, 4

Key mechanisms include:

  • Loss of tactile feedback: Cutaneous mechanoreceptor dysfunction in the fingers prevents normal sensory input needed for efficient grip force modulation 4

  • Compensatory grip force increase: Patients with sensory deficits characteristically produce markedly increased grip forces when holding objects—a strategic generalization to compensate for impaired sensory feedback 3

  • Impaired force efficiency: The ratio between grip force and actual load becomes significantly elevated, indicating inefficient force control when cerebral sensorimotor areas are functionally impaired 3

Common Clinical Scenarios

This sensorimotor pattern occurs in:

  • Acute stroke: Patients with mild to moderate paresis and sensory deficits exhibit both increased grip forces and impaired temporal coupling between grip and load forces 3, 5

  • Peripheral neuropathy: Large fiber sensory neuropathy causes marked abnormalities in grip strength, tactile sensation at fingertips, and motor control of precision grip 4

  • Parietal lobe lesions: Result in decreased frequency and regularity of exploratory finger movements with marked increase in exploration space, particularly with anterior parietal involvement 2

Documentation Recommendations

When documenting this clinical finding, specify:

  • Motor component: Quantify grip strength using dynamometry or manual muscle testing (graded 0-5 scale) 1

  • Sensory component: Document specific modalities affected (light touch, proprioception, stereognosis) and severity 1

  • Functional impact: Note specific deficits in activities of daily living, such as inability to safely hold cups or manipulate pens 1

The term "sensorimotor deficit" or "sensorimotor impairment" should be used in clinical documentation, as it accurately captures both components and is recognized across rehabilitation and neurology guidelines. 1

Related Questions

What is the diagnosis and recommended treatment for a 48-year-old female with a history of allergies, presenting with burning, swelling, and tingling in both hands, particularly in the fingers and thumbs, and negative Electromyography (EMG) studies?
Will using a splint on my middle finger, which has demyelization inflammatory damage to the nerve due to a needlestick injury (NSI), help it recover?
What laboratory tests should be ordered for a patient presenting with numbness of fingers to rule out underlying conditions?
What specific electrodiagnostic tests, such as Electromyography (EMG) and Nerve Conduction Studies (NCS), can help delineate isolated right 4th and 5th finger extension weakness?
To which doctor should a patient with bilateral hand numbness be referred?
In adults aged 60 years or older with age‑related cognitive decline or mild cognitive impairment, which proanthocyanidin preparations show the most promise for improving cognitive function?
How should a base of the fifth metatarsal fracture be managed in adults, considering fracture zone (avulsion zone I versus Jones zone II versus zone III), degree of displacement, activity level, and comorbidities such as diabetes, smoking, peripheral vascular disease, or chronic steroid use?
For an adult with relapsing‑remitting multiple sclerosis (RRMS) or primary‑progressive multiple sclerosis (PPMS) who has no active infection, hepatitis B, or severe allergy to monoclonal antibodies, what is the recommended Ocrevus (ocrelizumab) dosing schedule, pre‑infusion screening and premedication, monitoring requirements, contraindications, common adverse effects, and alternative disease‑modifying therapies?
In a patient ≥60 years old with age‑related cognitive decline or mild cognitive impairment (MCI), what are the optimal dietary sources of proanthocyanidins?
How can I differentiate the arthralgia of dengue from that of chikungunya, and what are the appropriate management strategies for each?
Is it safe for a stable adult with multiple sclerosis receiving ocrelizumab (Ocrevus) to start desvenlafaxine for depression, and what monitoring (blood pressure, infection) is needed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.